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Abstract
An 8.5-year-old girl was referred with swelling of both knees lasting for two years. ANA was found
as negative. She was diagnosed as oligoarticular JIA. After two years of follow-up,
thrombocytopenia was detected during routine screening. Her ANA and anti ds-DNA antibodies
also became positive, with low levels of C3 and C4. She was diagnosed as Juvenile SLE, meeting the
criteria cytopenia, positive immunoserology (anti dsDNA), positive ANA test, and four years of
ongoing chronic arthritis, so called as "rhupus arthropathy". We should be aware of the several
initial incomplete presentations of lupus in children. We should be careful in monitoring the serious
manifestations of the disease in juvenile lupus patients with rhupus arthropathy, and consider the
poor response to standard disease modifying agents.
Background
Systemic lupus erythematosus (SLE) is an episodic, mult-
isystem, autoimmune rheumatic disease characterized by
diversity of both clinical and immunological abnormali-
ties [1,2]. Arthralgia and arthritis affect the majority of
children with SLE [1]. The arthritis is characteristically
short in duration, lasting 24 to 48 hours, and can be
migratory [1]. In some children, the arthritis is persistent
and is characterized by swelling, tenderness, and loss of
range of motion. Although the synovitis of SLE may be
minimally proliferative, it is only occasionally erosive and
usually does not result in permanent deformity [1]. SLE
can mimic JIA, especially when it is presented as chronic
and erosive arthritis. A young lady with chronic oligoar-
thritis is presented here, whose clinical picture eventually
turned out to be typical lupus.
Case report
An 8.5 year-old-girl was referred with swelling of both
knees lasting for two years. She did not have complaints
in any other joints. On her first examination, she was
growing well. She had bilateral effusions of the knees (fig-
ure 1), and the other joints and systems were normal. MRI
of both knees with gadolinium demonstrated chronic
inflammation with synovial thickening (figure 2 and 3),
suggesting erosive arthritis. Initial laboratory results
revealed normal complete blood count (CBC), urine anal-
ysis, complement levels and immunoglobulin levels. ANA
was also negative. She was diagnosed as oligoarticular JIA;
naproxen was commenced, and she was regularly fol-
lowed at 3 month intervals. She did not have any symp-
toms consistent with lupus such as alopecia, facial rash or
oral ulcers. After two years of follow-up, she had a flare-up
of arthritis in the knees, and epistaxis at the age of 10.5
years. Laboratory results revealed thrombocytopenia
(23,000/mm3), coombs negative anemia (Hb: 10.7 g/dl),
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and normal WBC count (5900/mm3). ANA was positive
(1/1280, speckled pattern), anti-dsDNA level was 1/20
positive, rheumatoid factor level was 9.88 IU/ml (0–14
IU/ml), C3 (75.7 mg/dl) and C4 (5.4 mg/dl) levels were
low. Antiphospholipid antibodies were negative. Tests for
anti-extractable nuclear antigens (ENA) (SSA, SSB, SM,
SM/RNP, SCL-70 and Jo-1), were also negative. She did
not have proteinuria. The antibodies for Ebstein Barr
virus, parvo virus B19, and rubella were negative. She also
had a palpable thyroid gland. Thyroid function tests were
suggestive of Hashimoto thyroiditis: Free T3: 3.87 pg/ml
(1.8–4.2 pg/ml), free T4: 1.36 ng/dl (0.8–1.9 ng/dl), TSH:
12 uIU/ml (0.4–5.0 uIU/ml), ATG > 3000 IU/ml (0–50
IU/ml), ATA: 455 IU/ml (0–50 IU/ml). She was diag-
nosed as Juvenile SLE, after four years of ongoing chronic
arthritis. Prednisone (1 mg/kg/day) and methotrexate
(MTX)(15 mg/m2/week) were started. She was under con-
trol within the first month, complement levels became
normal and anti-dsDNA became negative. Prednisone
was gradually reduced to low dose. She had a systemic
flare of lupus at the age of 12, with high fever, alopecia,
arthritis of both wrists and left third PIP. Direct Coombs
IgG became positive without overt hemolytic anemia. She
was under control with oral prednisone (1 mg/kg/day).
She is now thirteen years old. A recent exacerbation of
arthritis in the knees with no other joint involvement was
controlled with intra-articular steroids. RF is still negative.
ENA tests are also negative. She is on MTX treatment (15
mg/week) with oral prednisone (5 mg/day).
Discussion
Systemic lupus erythematosus ranges from an insidious,
chronic illness with history of intermittent signs and
symptoms to an acute and rapidly fatal disease [1]. Artic-
ular symptoms are the most common clinical manifesta-
tion of SLE [3,4]. Joint involvement occurs in
approximately 90% of patients at sometime during the
course of their disease [3,5]. Arthritis commonly involves
the small joints of the hands, wrists, elbows, shoulders,
knees, and ankles [1]. The degree of involvement may
range from minor arthralgia to severe deforming arthritis
[4]. Joint pain is often severe even though objective find-
ings are minimal [1]. Although joint pain and swelling are
common features of SLE, erosive arthritis is generally
reported rarely (<5%) in patients [2].
In the historical evaluation of SLE patients with chronic
arthritis, Fallet mentioned a familial coexistence of
chronic polyarthritis and lupus in 1963 [6]. Kantor
reported a case in 1969 having both RA (Rheumatoid
Arthritis) and SLE [7]. Labowitz et al [3] reviewed 25 SLE
patients retrospectively in 1971, and six of them were
found to have persistent arthritis lasting from six to twelve
months, and they were first diagnosed as RA. Brzezinska
reported a case with coexistence of RA and SLE in 1973
[8], and Meijers [9] presented a case with chronic synovi-
tis as an unusual manifestation of SLE, in 1978. Fishman
[10] in 1981 and Isenberg [11] in 1982 reported cases,
which had RA as an initial diagnosis, and they were classi-
fied as SLE after many years. Tauchi demonstrated the
coexistence of the two diseases in 2 sisters, who also had
Marfan syndrome, in 1985 [12]. Venegoni reported a 29-
year-old white female in 1987, who developed SLE with
diffuse proliferative glomerulonephritis following long
standing RA [13]. Cohen et al [14] reported 11 patients
with RA and SLE in 1987, which showed that the coexist-
ence of two diseases was not rare as it was thought to be.
They suggested that erosive arthritis was not a feature of
SLE, but concomitant RA. In the same year, Martini [15]
reported an 11-year-old girl in 1987, who was initially
diagnosed as JRA at the age of five. She developed SLE
after 6 years, and the author pointed out that Jaccoud's
type chronic arthropathy might be an initial manifesta-
tion of SLE. Panush et al [16] reviewed children who had
both SLE and JRA in 1988. They were adolescent girls with
polyarthritis, subcutaneous nodules, malar or discoid
type rashes, photosensitivity and nephritis. They were
found to have erosive arthritis and RF positivity, along
with ANA positivity and hypocomplementemia. They had
autoimmune type thrombocytopenia. Our patient also
had the same type of thrombocytopenia; however, she did
not have RF positivity. It might be due to her younger age
at onset. Cassidy stated that RF was found as positive in
children with later age of disease onset and polyarticular
disease. They might be a result rather than a determining
event in children who will have disabling disease course
in their early adulthood years [17]. In a study by Segovia
et al [18] in 1988, 858 patients with SLE were reviewed,
and 41 of them were found to have deformities of the
hands. These patients had more rheumatoid factor (RF)
positivity with sicca symptoms, and anti ds-DNA antibod-
ies. Brand [19] reported 11 patients in 1992 that fulfilled
the criteria of both RA and SLE. All patients had a symmet-
rical small joint polyarthritis and features of SLE such as
rash, photosensitivity, oral ulceration, serositis, cytope-
nia, and biopsy proven lupus nephritis. Eight had
hypocomplementemia. Autoantibodies were characteris-
tic of the two diseases: all patients had rheumatoid factor
and antibodies to double stranded DNA, eight (73%) had
antibodies to collagen, and five (46%) had antibodies to
Ro (SS-A). There was also an overlap of HLA phenotypes.
Six patients were DR4 and seven were DR2 or DR3 posi-
tive, and of the five patients who were DR4 negative, four
shared class I alleles often associated with DR4. He sug-
gested if the cases had both RA and SLE, they shared a
common autoimmune dysfunction. Takei et al reported
two cases with SLE and MCTD in 1997, who were first
diagnosed as JRA [20], and after 8 years their ANA and anti
ds-DNA levels became positive with the onset of clinical
picture of SLE, a similar picture as our patient. EisenbergPediatric Rheumatology 2007, 5:7 http://www.ped-rheum.com/content/5/1/7
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et al [21] documented the long term follow-up of 21
patients with systemic onset JIA in 1999, five of them
developed chronic destructive arthritis, and one of those
had SLE after eight years.
Panush first used the term 'rhupus syndrome' in 1988 to
describe patients with overlapping signs and symptoms of
RA and SLE. He mentioned that it was unclear whether
patients with rhupus represented a distinct clinical and
immunologic entity, or the coincidental occurrence of RA
and SLE [16]. Simon et al [22] in 2002 described 22 Mexi-
can patients with rhupus, all of them had erosive arthritis;
they also demonstrated that HLA-DR1 and HLA-DR2 alle-
les were significantly increased in this group. Ostendorf
[23] in 2003 demonstrated the difference between Rhupus
and Jaccoud's arthropathy, by demonstrating the destruc-
tive character of Rhupus arthropathy in MRI. Fernandez et
al [24] in 2004 reviewed the 'historical evolution' of lupus
arthropathy. They described rhupus arthropathy as one of
the serious articular involvement of lupus, rather than a
superposition, or overlap of RA and SLE. Recently, they
published a series of 8 patients with rhupus arthropathy
between 17 and 38 years at the disease onset [25] in 2006.
Seven of them were women, and the diagnosis was RA in 7
patients (including the male patient) at the beginning. They
developed SLE after an average of 2.8 years (range: few yrs.
to 5 years). Similarly, SLE was diagnosed after four years of
rhupus arthropathy in our patient. The therapeutic
response to disease modifying agents was not as successful
as the ones in classical RA. More important, serious mani-
festations of SLE were common, such as glomerulonephri-
tis and CNS disease with seizures. The importance of serum
anti-cyclic citrullinated peptide antibodies (anti-CCP) lev-
els in patients with RF positivity and/or in patients with
erosive joint disease was highlighted by Low [26], Kas-
apcopur [27] and Kwok [28]. They found high levels of
anti-CCP antibodies in polyarticular JIA patients with ero-
sive arthritis. Recently, Amezcua-Guerra [29] studied the
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prevalence of antibodies against anti-CCP antibodies in
rhupus. They categorized rhupus as an overlap between RA
and SLE, because of the positivity of anti-CCP, anti-dsDNA
and anti-Sm antibodies in the related patients.
In conclusion, our patient has the rare features of SLE as
rhupus arthropathy. We should be careful in monitoring
the serious manifestations of the disease in juvenile lupus
patients with rhupus arthropathy, and consider the poor
response to standard disease modifying agents.
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